Abstract 2485: Secretome signature associated with TITF1/NKX2-1-negative non-small cell lung cancer

Conclusion: Our findings suggest functional relevance of SRGN in tumor microenvironment and tumor aggressiveness in TITF1/NKX2-1-negative NSCLC. Validation study for plasma levels of CXCL1 and CXCL5 in NSCLC subjects is now on-going.
Citation Format: Ayumu Taguchi, Muge Celiktas, Dhillon Dilsher, Qing Zhang, Chee-Hong Wong, Alice Chin, Adi Gazdar, Samir Hanash. Secretome signature associated with TITF1/NKX2-1-negative non-small cell lung cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2485. doi:10.1158/1538-7445.AM2014-2485

Source: Cancer Research - September 30, 2014 Category: Cancer & Oncology Authors: Taguchi, A., Celiktas, M., Dilsher, D., Zhang, Q., Wong, C.-H., Chin, A., Gazdar, A., Hanash, S. Tags: Cancer Chemistry Source Type: research